← Back
Data updated: Jul 17, 2026
REED AND CARNRICK
Generics Pharmaceuticals
REED AND CARNRICK is a generic drug manufacturer with 1 FDA-approved products.
1974
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
REED AND CARNRICK's Key Drugs
REED AND CARNRICK's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
REED AND CARNRICK's Recent FDA Approvals
New NDA/BLA approvals for REED AND CARNRICK over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
REED AND CARNRICK's Therapeutic Areas
Disease areas where REED AND CARNRICK has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
REED AND CARNRICK Pipeline Snapshot
Active clinical trials for REED AND CARNRICK across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1974-12-19
- Latest
- 1975-01-22
- Applications
- 4